Department of Medical Oncology, The Oncology Institute "Prof. Dr. Ion Chiricuta", Cluj-Napoca, Romania.
MEDFUTURE-Research Center for Advanced Medicine, University of Medicine and Pharmacy Iuliu-Hatieganu, Cluj-Napoca, Romania.
J Cell Physiol. 2020 Feb;235(2):691-705. doi: 10.1002/jcp.29096. Epub 2019 Jul 21.
Breast cancer is a heterogeneous disease, with a morbidity rate of 27.8% and a mortality rate of 15% among women population worldwide. Understanding how this cancer develops and the mechanisms behind tumor progression and chemoresistance is of utmost importance. Exosomes mediate communication in a population of heterogeneous tumoral cells. They have a cargo composed of oncogenes and oncomiRs which change the transcriptomic scenario of their targeted cells and activate numerous tumor-promoting signaling pathways. Exosomes secreted by breast cancer cells lead to enhanced cell proliferation, replicative immortality, angiogenesis, invasion, migration, and chemoresistance. Studying exosomes from this perspective offers more in depth understanding of breast malignancy and may aid in the future development of early diagnostic, prognostic and therapeutic options. We present the latest findings in this area and offer practical solutions which may further stimulate the much-needed research of exosome in breast cancer.
乳腺癌是一种异质性疾病,全球女性的发病率为 27.8%,死亡率为 15%。了解这种癌症的发展以及肿瘤进展和化疗耐药的机制至关重要。外泌体在异质性肿瘤细胞群体中介导通讯。它们的货物由致癌基因和致癌 miRNA 组成,这些基因改变了其靶细胞的转录组图谱,并激活了许多促进肿瘤的信号通路。乳腺癌细胞分泌的外泌体导致细胞增殖、复制性永生、血管生成、侵袭、迁移和化疗耐药性增强。从这个角度研究外泌体可以更深入地了解乳腺癌的恶性程度,并可能有助于未来开发早期诊断、预后和治疗选择。我们介绍了该领域的最新发现,并提供了实用的解决方案,这可能会进一步激发对乳腺癌中外泌体研究的迫切需求。